Lam Research (NASDAQ:LRCX) Given New $275.00 Price Target at UBS Group

Lam Research (NASDAQ:LRCX) had its target price hoisted by UBS Group from $255.00 to $275.00 in a report issued on Thursday morning, Marketbeat reports. UBS Group currently has a buy rating on the semiconductor company’s stock.

Several other analysts have also recently weighed in on the stock. Jefferies Financial Group restated a “buy” rating and set a $200.00 price objective (up previously from $175.00) on shares of Lam Research in a research report on Monday, December 15th. B. Riley restated a “buy” rating on shares of Lam Research in a research report on Thursday, January 15th. TD Cowen raised their price target on shares of Lam Research from $170.00 to $290.00 and gave the stock a “buy” rating in a report on Thursday. Susquehanna set a $325.00 price objective on Lam Research and gave the stock a “positive” rating in a research report on Thursday. Finally, Dbs Bank lifted their target price on shares of Lam Research from $119.40 to $184.20 in a research note on Monday, October 27th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-seven have issued a Buy rating and seven have assigned a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $234.55.

Lam Research Price Performance

Shares of NASDAQ:LRCX opened at $248.17 on Thursday. The company has a 50 day moving average of $185.48 and a 200 day moving average of $145.09. The company has a current ratio of 2.21, a quick ratio of 1.60 and a debt-to-equity ratio of 0.37. Lam Research has a 12 month low of $56.32 and a 12 month high of $251.38. The stock has a market cap of $311.71 billion, a P/E ratio of 50.85, a P/E/G ratio of 3.03 and a beta of 1.77.

Lam Research (NASDAQ:LRCX) last released its quarterly earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share for the quarter, topping the consensus estimate of $1.17 by $0.10. The firm had revenue of $5.34 billion for the quarter, compared to analysts’ expectations of $5.23 billion. Lam Research had a net margin of 30.22% and a return on equity of 63.28%. The business’s quarterly revenue was up 22.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.91 earnings per share. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. As a group, sell-side analysts forecast that Lam Research will post 3.71 EPS for the current fiscal year.

Lam Research Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, January 7th. Stockholders of record on Wednesday, December 3rd were issued a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a dividend yield of 0.4%. The ex-dividend date of this dividend was Wednesday, December 3rd. Lam Research’s payout ratio is presently 21.31%.

Insiders Place Their Bets

In other Lam Research news, Director Bethany Mayer sold 1,298 shares of the company’s stock in a transaction that occurred on Monday, November 3rd. The shares were sold at an average price of $159.99, for a total transaction of $207,667.02. Following the completion of the sale, the director directly owned 1,652 shares of the company’s stock, valued at approximately $264,303.48. This represents a 44.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Douglas R. Bettinger sold 40,080 shares of Lam Research stock in a transaction on Friday, November 14th. The stock was sold at an average price of $150.60, for a total transaction of $6,036,048.00. Following the transaction, the chief financial officer owned 987,237 shares in the company, valued at $148,677,892.20. This represents a 3.90% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 41,408 shares of company stock worth $6,248,501. Company insiders own 0.31% of the company’s stock.

Institutional Investors Weigh In On Lam Research

Several hedge funds and other institutional investors have recently modified their holdings of LRCX. PMV Capital Advisers LLC bought a new stake in Lam Research during the fourth quarter valued at about $25,000. IMG Wealth Management Inc. purchased a new position in shares of Lam Research during the 2nd quarter valued at about $26,000. Stance Capital LLC bought a new position in shares of Lam Research during the 3rd quarter valued at approximately $26,000. Howard Hughes Medical Institute purchased a new stake in Lam Research in the 2nd quarter worth approximately $27,000. Finally, Triumph Capital Management purchased a new stake in Lam Research in the 3rd quarter worth approximately $27,000. 84.61% of the stock is currently owned by hedge funds and other institutional investors.

Key Stories Impacting Lam Research

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Q2 results beat expectations — EPS $1.27 vs. $1.17 est., revenue $5.34B (+22% Y/Y); company issued stronger-than-expected Q3 revenue and EPS guidance. PR News Release
• Positive Sentiment: Management pointed to robust AI-driven demand and higher bookings, prompting commentary that the quarter was “extraordinarily bullish” from some outlets — supportive for near-term revenue visibility. Barron’s: Why Earnings Were ‘Extraordinarily Bullish’
• Positive Sentiment: Large wave of analyst price-target increases and upgrades after results (JPMorgan, Citi, UBS, Wells Fargo, Deutsche Bank, Stifel, Needham, TD Cowen, Summit upgrades), reflecting consensus optimism on demand and execution. Benzinga roundup of analyst boosts
• Positive Sentiment: High-profile bull commentary (Jim Cramer) highlighting structural shortage/strong demand for Lam’s tools — supports momentum and retail/institutional interest. InsiderMonkey: Jim Cramer on Lam Research
• Neutral Sentiment: Deep-dive coverage and investor takeaways highlight expansion plans and capex exposure as Lam scales production to meet wafer-equipment demand — positive for growth but capex cadence can fluctuate results. Yahoo Finance: LRCX Q4 Deep Dive
• Negative Sentiment: Valuation questions: coverage notes and some analysts caution about elevated multiples after the rally; Forbes flags the stock’s history of sharp pullbacks — risk of volatility despite strong results. Forbes: Record Highs May Face Reality Check
• Negative Sentiment: One analyst (Morgan Stanley) keeps an equal-weight rating with a lower target vs. several bullish upgrades — a reminder not all houses are uniformly bullish and limiting near-term upside for cautious funds. Benzinga: Morgan Stanley note

Lam Research Company Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.